Compared to a three out of 30 survival rate of dogs receiving chemotherapy to treat osteosarcoma, five out of 10 dogs survived the immunotherapy trial.
The scanner, a $3 million investment, will be used to further treatment for cancer, among other chronic diseases, associate oncology professor Dr. Jeffrey Bryan said.
The project is expected to last three years and will involve various experiments involving ticks and cattle to study their responses to deadly pathogens.
The new method has proven effective MU researchers have made progress on a new prostate cancer treatment method.
MU’s College of Veterinary Medicine introduces MRI technology applied to equine athletes.
Watson the bald eagle was released Jan. 8.